Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GRIK1 | P39086 | 13/20 | 0.73 |
| ▸ | GRIK2 | Q13002 | 12/20 | 0.73 |
| ▸ | HTR2A | P28223 | 3/20 | 0.59 |
| ▸ | GRIK3 | Q13003 | 2/20 | 0.56 |
| ▸ | PAM | P19021 | 1/20 | 0.53 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL504608 | 1.00 | GRIK1 (0.73) | GRIK1GRIK2HTR2AGRIK3PAM | |
| SCHEMBL1865552 | 1.00 | GRIK1 (0.73) | GRIK1GRIK2HTR2AGRIK3PAM | |
| SCHEMBL3579937 | 1.00 | GRIK1 (0.73) | GRIK1GRIK2HTR2AGRIK3PAM | |
| SCHEMBL8087387 | 1.00 | GRIK1 (0.73) | GRIK1GRIK2HTR2AGRIK3PAM | |
| SCHEMBL1865554 | 1.00 | GRIK1 (0.73) | GRIK1GRIK2HTR2AGRIK3PAM | |
| SCHEMBL594002 | 0.85 | GRIK1 (1.00) | GRIK1GRIK2GRIK3 | |
| SCHEMBL594001 | 0.85 | GRIK1 (1.00) | GRIK1GRIK2GRIK3 | |
| SCHEMBL594000 | 0.85 | GRIK1 (1.00) | GRIK1GRIK2GRIK3 | |
| SCHEMBL593999 | 0.85 | GRIK1 (1.00) | GRIK1GRIK2GRIK3 | |
| SCHEMBL2354701 | 0.84 | GRIK1 (0.55) | GRIK1GRIK2GRIK3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20100048549-A1 | Peptidomimetics selective for the somatostatin receptor subtypes 1 and/or 4 | Wurster, Siegfried (FI) | 2010-02-25 | — | — | US | disclosed |
| EP-1885693-A1 | PEPTIDOMIMETICS SELECTIVE FOR THE SOMATOSTATIN RECEPTOR SUBTYPES 1 AND/OR 4 | Wurster, Siegfried (FI) | 2008-02-13 | — | — | EP | disclosed |
| WO-2006123020-A1 | PEPTIDOMIMETICS SELECTIVE FOR THE SOMATOSTATIN RECEPTOR SUBTYPES 1 AND/OR 4 | JUVANTIA PHARMA LTD OY (FI) | 2006-11-23 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100048549-A1 | Peptidomimetics selective for the somatostatin receptor subtypes 1 and/or 4 | SSTR1, SSTR4, SSTR3 | GRIK1 476/4885GRIK2 1178/4885HTR2A 439/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.